News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 1155
- Sources here
- 26
- Companies here
- 17
Active search
1155 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Galaxy Digital director Douglas Deason buys $258k in stock
Douglas R. Deason, a director at Galaxy Digital Inc., purchased 12,000 shares of the company's Class A Common Stock for over $258,000. This insider purchase comes as the stock trades near its 52-week low, and InvestingPro analysis suggests it is undervalued. Despite a recent …
Galectin Therapeutics reports Q2 2026 net loss $9.2M, cash $13.3M, submits Phase 3 protocol
Galectin Therapeutics reported a Q2 2026 net loss of $9.2 million and held $13.3 million in cash. The company plans to submit a registrational Phase 3 protocol for belapectin in advanced MASH cirrhosis in Q3 2026, having aligned with the FDA on key trial …
Galectin Reports $9.1 Million Q2 Net Loss and FDA Phase 3 Agreement
Galectin Therapeutics (GALT) announced a net loss of $9.1 million for Q2 2026, or $0.14 per share, an increase from $7.6 million in the prior-year quarter. The company also reached an agreement with the FDA on key elements for its planned Phase 3 belapectin …
Insider Buys Additional US$100k In Galaxy Digital Stock
Independent Director Steven Bandrowczak recently purchased US$100k worth of Galaxy Digital (NASDAQ: GLXY) stock, although this was a small percentage increase in his holdings. Over the past year, insiders have sold more shares than they bought, with the largest sale being US$27m by President …
Galaxy Digital (NASDAQ:GLXY) Director Douglas Deason Acquires 12,000 Shares of Stock
Galaxy Digital Director Douglas Deason recently purchased 12,000 shares of the company's stock for $258,480, increasing his total holdings to 71,000 shares. The transaction, disclosed on August 12th, raises his position by over 20%. Despite a quarterly loss, Galaxy Digital surpassed analyst estimates, and …
5 Insightful Analyst Questions From LegalZoom’s Q2 Earnings Call
5 Insightful Analyst Questions From LegalZoom's Q2 Earnings Call LegalZoom's second quarter results reflected the impact of rapid changes in online search dynamics. Management attributed the quarter's performance to a mix of solid subscription growth and the accelerating adoption of AI-powered services, but also …
5 Must-Read Analyst Questions From Regal Rexnord’s Q2 Earnings Call
5 Must-Read Analyst Questions From Regal Rexnord's Q2 Earnings Call Regal Rexnord's second quarter saw its sales growth fall short of Wall Street's expectations, driving a significant negative market reaction. Management attributed the shortfall to persistent weakness in residential HVAC and pool markets, as …
Bit Digital pledged 74% of its staked Ethereum position to a loan that can trigger a 24-hour collateral call
Bit Digital pledged 49,000 LsETH, valued at $105.6 million, to secure a $50 million loan from Galaxy Digital to fund its AI infrastructure company, WhiteFiber. This arrangement means a significant portion of its staked Ethereum is now collateral, subject to a 24-hour margin call. …
RRX|Regal Rexnord Corp|Price:172.306|Chg%:-0.594
This article provides a detailed financial overview of Regal Rexnord Corp (RRX), including its stock price, key figures, and recent performance. It highlights the company's stock score, analyst ratings, and technical analysis, showing a "Buy" consensus with a target price significantly above the current …
HII Looks 8.7% Overvalued on GF Value™ Amid Naval Redesign Mandate
Huntington Ingalls Industries Inc (HII) is deemed 8.7% overvalued by GuruFocus' GF Value™ metric, trading at $325.76 against an intrinsic value of $299.57. This assessment comes amidst a presidential mandate to revert to steam-powered catapults for future aircraft carriers, potentially causing contract delays and …
GLXY to BDT: Galaxy Digital Inc. • Robinhood Token Price in Bangladeshi Taka
The article provides the current price of Galaxy Digital Inc. • Robinhood Token (GLXY) in Bangladeshi Taka (BDT), which is ৳2,609.73. It details how to buy GLXY using BDT, including identifying exchanges, setting up a crypto wallet, and making the trade. The piece also …
Bank Leumi Taps Galaxy Digital to Put Bitcoin Directly in Israeli Banking Apps
Bank Leumi, Israel's oldest commercial bank, has partnered with Galaxy Digital and its subsidiary GK8 to allow Bitcoin, Ethereum, and Solana trading directly within its banking apps, aiming for a 2027 launch pending Bank of Israel approval. This marks a significant move, especially after …
Galaxy Digital (NASDAQ:GLXY) Trading 6.7% Higher - Time to Buy?
Galaxy Digital (NASDAQ:GLXY) saw its shares increase by 6.7% to $22.50, despite significantly lower trading volume. Analysts maintain a "Moderate Buy" rating with an average price target of $38.83, following an earnings beat but continued negative net margin and return on equity. Insider activity …
Galaxy Digital Inc. Class A Bonds — Corporate Bond Rates
This article provides information on Galaxy Digital Inc. Class A corporate bonds, specifically highlighting a bond from Galaxy Helios Data Centers II LLC. It lists details such as yield to worst, price, coupon, maturity date, outstanding amount, face value, and S&P rating. The content …
Huntington Ingalls stock steadies after $2.2 billion SOUTHCOM contract win
Huntington Ingalls Industries Inc. (HII) secured a $2.2 billion task order from the U.S. Southern Command for intelligence, surveillance, and reconnaissance capabilities, expanding its defense technology footprint. This contract, alongside a $900 million robotics partnership for shipbuilding automation, reinforces HII's strategic growth beyond traditional …
Galectin Therapeutics (NASDAQ:GALT) Upgraded to Hold at Zacks Research
Zacks Research upgraded Galectin Therapeutics (NASDAQ:GALT) from a "strong sell" to a "hold" rating. The company received a consensus "Hold" rating and an $11.00 target price from various analysts. Galectin Therapeutics' stock opened at $3.14, with a market capitalization of $206.8 million, and the …
Citigroup Adjusts PT on Huntington Ingalls Industries to $379 From $349, Keeps Buy Rating
Citigroup has increased its price target for Huntington Ingalls Industries (HII) to $379, up from $349, while maintaining a "Buy" rating on the stock. This adjustment reflects a positive outlook on the company's financial prospects and market performance.